Green Hypocrisy: Cannabis, Hemp, and Ireland's War on Common Sense

01 Introduction: Ireland's Green Contradiction

In Ireland, in 2026, you can walk into any off-licence and buy a bottle of vodka. You can light a cigarette outside a hospital. You can place a bet on your phone while sitting in the waiting room of a methadone clinic. But if a Garda finds a small bag of dried flowers in your pocket — flowers from a plant that has been cultivated by human beings for at least 10,000 years — you will be arrested, charged, and given a criminal record that will follow you for the rest of your life.

Cannabis remains fully criminalised in the Republic of Ireland. Under the Misuse of Drugs Act 1977 (as amended), possession of any amount for personal use is a criminal offence. A first offence can result in a fine of up to €1,000. A second offence: up to €2,500. A third offence: a criminal conviction and up to 12 months in prison.^[1] Possession with intent to supply carries a sentence of up to life imprisonment. Life. For a plant.

This is not a fringe position held by a government out of step with its electorate. In 2023, Ireland convened a Citizens' Assembly on Drug Use — a deliberative democratic exercise in which 99 randomly selected citizens heard evidence from experts, addicts, families, clinicians, police, and international observers over several months. They recommended, decisively, that Ireland should decriminalise the possession of drugs for personal use and adopt a health-led approach to drug policy.^[2]

The government acknowledged the recommendations. Then it did nothing.

Meanwhile, the rest of the developed world has moved on. Canada legalised cannabis in 2018. Germany followed in 2024. Twenty-four US states and the District of Columbia have legalised recreational use. Portugal decriminalised all drugs in 2001 and has 20 years of data proving the policy works. Uruguay became the first country to fully legalise in 2013. Malta became the first EU member state to legalise in 2021. Thailand legalised, then partially reversed course. The Netherlands has operated a tolerance policy for decades.

Ireland, a country that prides itself on progressive social reform — the country that legalised same-sex marriage by popular vote and repealed the Eighth Amendment on abortion — clings to drug prohibition like a comfort blanket. The contradiction is not subtle. It is glaring, embarrassing, and costly — in human terms, in economic terms, and in democratic terms.

This investigation examines why. It traces the racist origins of cannabis prohibition in the United States. It documents the industrial destruction of hemp — one of the most versatile crops on Earth. It analyses the Citizens' Assembly's recommendations and the government's failure to act on them. It presents the global evidence. It calculates the economic opportunity Ireland is squandering. And it proposes a model for drug policy and criminal justice reform that is both humane and hard-nosed.

The evidence is in. The verdict is unanimous. Ireland's cannabis laws are a monument to cowardice, inherited racism, and wilful economic self-harm.

02 The Origins of Prohibition: America's Racist Drug War

To understand why cannabis is illegal in Ireland, you have to understand why it became illegal in the United States. Because Ireland's drug laws — like those of most Western countries — were not designed in Dublin. They were designed in Washington, DC, by men whose primary motivation was not public health, but racial control.

Harry Anslinger and the Birth of Reefer Madness

In 1930, Harry J. Anslinger was appointed the first commissioner of the newly created Federal Bureau of Narcotics (FBN). Anslinger was a career bureaucrat who had cut his teeth during Prohibition, and when alcohol was re-legalised in 1933, he needed a new enemy to justify his bureau's existence and budget. He found one in cannabis — or, as he deliberately re-branded it, marijuana.^[3]

The word “marijuana” was not an accident. Cannabis had been widely used in American medicine and industry. Tinctures of cannabis were sold in pharmacies. Hemp was one of America's most important agricultural crops — George Washington and Thomas Jefferson both grew it. The word “cannabis” was clinical, familiar, unthreatening. Anslinger deliberately adopted the Mexican-Spanish slang term marihuana to associate the drug with Mexican immigrants and Black jazz musicians — populations that white America already feared and despised.

Anslinger's campaign was built on racism, fabrication, and moral panic. He told Congress that marijuana caused insanity, violence, and sexual degeneracy — particularly among Black men. He collected what he called his “Gore File” — a dossier of violent crimes he attributed to marijuana, most of which had no verified connection to the drug. He told the press: “Reefer makes darkies think they're as good as white men.” He warned that marijuana led Black men to seek sexual relations with white women.^[4]

The American Medical Association (AMA) opposed criminalisation. Dr. William C. Woodward, the AMA's legislative counsel, testified before Congress in 1937 that there was no scientific evidence to support Anslinger's claims and that the term “marihuana” had been deliberately used to obscure the fact that the bill targeted cannabis. He was shouted down. The committee chairman reportedly told him: “If you can't say something good about what we are trying to do, why don't you go home?”^[5]

The Marihuana Tax Act of 1937 passed with almost no debate, no scientific evidence, and against the explicit opposition of the medical profession. Cannabis was effectively criminalised across the United States.

Nixon's War on Drugs: The Quiet Part Out Loud

If Anslinger laid the foundation, Richard Nixon built the fortress. In 1971, Nixon declared drug abuse “public enemy number one” and launched the War on Drugs. He created the Drug Enforcement Administration (DEA). He placed cannabis in Schedule I — the most restrictive category, alongside heroin — defined as having “no accepted medical use” and a “high potential for abuse.” This scheduling has persisted for over 50 years, despite overwhelming evidence that cannabis has legitimate medical applications and a lower potential for harm than alcohol or tobacco.

Nixon's own commission — the Shafer Commission, which he personally appointed — recommended in 1972 that cannabis possession should be decriminalised. Nixon rejected its findings and buried the report.^[6]

But the most damning evidence of Nixon's true motivation came decades later. In 1994, John Ehrlichman — Nixon's domestic policy advisor, who served 18 months in prison for his role in Watergate — gave an interview to journalist Dan Baum. It was published in Harper's Magazine in 2016:

There it is. From the mouth of the man who designed the policy. The War on Drugs was never about drugs. It was about race and political power.

Reagan, Crack, and the Sentencing Disparity

Ronald Reagan escalated Nixon's war into a full-blown crusade. The Anti-Drug Abuse Act of 1986 introduced mandatory minimum sentences for drug offences. It created the infamous 100:1 sentencing disparity between crack cocaine and powder cocaine: possession of 5 grams of crack (predominantly used in Black communities) carried the same mandatory minimum sentence as possession of 500 grams of powder cocaine (predominantly used by white Americans). Same drug, different form, wildly different punishment — and the disparity fell almost exclusively along racial lines.^[8]

The three-strikes laws that followed meant that three drug offences — even non-violent possession — could result in life imprisonment. The prison population in the United States exploded. In 1980, there were approximately 40,000 people in US prisons for drug offences. By 2023, the total incarcerated population had reached over 2 million, with drug offences accounting for nearly half of federal prisoners.^[9]

The Global Export of Prohibition

The United States did not simply criminalise cannabis at home. It exported prohibition worldwide. Through a combination of UN treaties, bilateral agreements, and diplomatic pressure, Washington embedded cannabis prohibition into international law.

The 1961 Single Convention on Narcotic Drugs — negotiated under intense US pressure — required signatory nations to criminalise cannabis. The 1971 Convention on Psychotropic Substances and the 1988 Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances reinforced these obligations. Countries that resisted faced trade consequences, aid withdrawal, and diplomatic isolation.^[10]

Ireland signed all three conventions. Its Misuse of Drugs Act 1977 was, in essence, an act of compliance with American foreign policy objectives rooted in racial politics. Irish legislators in 1977 were not responding to an Irish drug crisis. They were implementing a framework designed in Washington to target Black Americans and anti-war protesters.

Every time an Irish person is prosecuted for cannabis possession, they are being punished under a legal framework that was designed — explicitly, by its own architects' admission — as a tool of racial oppression. That is not hyperbole. It is documented history.

03 Hemp: The Industrial Casualty

When Harry Anslinger criminalised cannabis, he did not just target a recreational drug. He destroyed an entire industry. Hemp and psychoactive cannabis are the same species — Cannabis sativa — but they are fundamentally different varieties. Industrial hemp contains less than 0.3% THC (the psychoactive compound). You could smoke a field of hemp and feel nothing but a headache. Yet hemp was swept up in the same prohibition that targeted marijuana, and one of humanity's oldest and most versatile crops was effectively banned for nearly a century.

A 10,000-Year Industrial History

Hemp is one of the earliest plants cultivated by human beings. Archaeological evidence of hemp textiles dates to approximately 8000 BC in Mesopotamia. The plant spread across every inhabited continent. Its uses are extraordinary in their breadth:

• Textiles: Hemp fibre is stronger, more durable, and more UV-resistant than cotton. It requires no pesticides and a fraction of the water. Hemp clothing softens with washing and lasts for decades.
• Paper: The first drafts of the US Declaration of Independence were written on hemp paper. Hemp produces four times more paper per acre than trees, and hemp paper can be recycled up to eight times (compared to three for wood-pulp paper).
• Building materials: Hempcrete — a mixture of hemp hurds, lime, and water — is a carbon-negative building material. It is breathable, moisture-regulating, fire-resistant, and an excellent insulator. It sequesters CO₂ during both the growing phase and the curing phase.
• Biofuel: Hemp biomass can be converted to biodiesel and ethanol. Henry Ford built a car partially made from hemp plastic and designed to run on hemp fuel in 1941.^[11]
• Food: Hemp seeds are a complete protein source, containing all 20 amino acids. Hemp oil is rich in omega-3 and omega-6 fatty acids. Hemp hearts are sold in every health food shop in Ireland — imported, because Ireland barely grows the plant they come from.
• Rope and sailcloth: The word “canvas” derives from “cannabis.” For centuries, every sailing ship in the world depended on hemp rope and hemp sails. The British Navy consumed 40,000 tonnes of hemp annually at its peak.
• Plastics and composites: Hemp fibre composites are increasingly used in automotive manufacturing, replacing fibreglass. BMW, Mercedes, and Porsche all use hemp-based composites in their vehicles.

Why Was Hemp Criminalised?

The most widely cited explanation involves two names: DuPont and Hearst. In the 1930s, the DuPont chemical company had recently patented nylon — a synthetic fibre that directly competed with hemp. William Randolph Hearst, the newspaper magnate, owned vast timber holdings that supplied his paper mills; hemp threatened his business model. Both had financial incentives to see hemp banned, and both had close relationships with Anslinger's bureau.

The conspiracy theory — that DuPont and Hearst actively lobbied for hemp prohibition to eliminate a commercial rival — has supporting circumstantial evidence but lacks a definitive smoking gun.^[12] The simpler and more likely explanation is regulatory laziness: when Congress criminalised “marihuana,” nobody bothered to distinguish between the psychoactive plant and its industrial cousin. It was easier to ban the whole species than to write nuanced legislation. The result was the same either way: hemp was destroyed as collateral damage.

Hemp in Ireland Today

The European Union permits the cultivation of industrial hemp with THC content below 0.3%. Ireland technically allows licensed hemp farming under the Misuse of Drugs Act, but the bureaucratic requirements are deliberately onerous. Farmers must obtain a licence from the Health Products Regulatory Authority (HPRA), comply with Garda inspections, and navigate a permit system designed for controlled substances rather than agricultural crops.^[13]

Despite these obstacles, a small but growing number of Irish farmers have begun cultivating hemp. The Irish Hemp Co-operative Society, founded to promote hemp farming and processing in Ireland, has advocated for regulatory reform and demonstrated the crop's viability in Irish conditions.^[14] Several small-scale hemp farms now operate across Ireland, producing fibre, seed, and CBD products — but the industry remains a fraction of what it could be.

The Economic Opportunity Ireland Is Missing

France is the EU's largest hemp producer, with over 21,000 hectares under cultivation. The European hemp market was valued at approximately €1.1 billion in 2023 and is projected to reach €3.3 billion by 2030.^[15] Ireland — with its ideal growing conditions, its agricultural expertise, its established food and pharmaceutical export infrastructure — could be a major player in this market. Instead, it imports hemp products that it could be growing and exporting.

The construction industry alone represents a massive opportunity. Ireland is in the grip of a housing crisis. Hempcrete construction is cheaper, faster, more sustainable, and more energy-efficient than conventional building methods. A domestic hemp supply chain for construction materials would reduce building costs, reduce carbon emissions, create agricultural jobs, and reduce dependence on imported materials.

But Ireland regulates hemp as a drug, not a crop. And so the opportunity sits there, untouched, while the country imports what it could grow in its own fields.

04 Ireland's Citizens' Assembly on Drug Use

In 2023, Ireland did something it should be proud of. It convened a Citizens' Assembly on Drug Use — the first of its kind anywhere in the world. The Assembly brought together 99 randomly selected citizens, broadly representative of the Irish population by age, gender, region, and socioeconomic background. Over several months, these citizens heard evidence from an extensive range of experts: clinicians, addiction specialists, people with lived experience of drug use and addiction, law enforcement officials, international policy experts, human rights advocates, and family members of those affected by drug use.^[16]

What the Assembly Recommended

The Assembly's recommendations were clear, evidence-based, and far-reaching:

• Decriminalisation of the possession of drugs for personal use. Not legalisation — decriminalisation. The Assembly recommended removing criminal penalties for personal possession and replacing them with health-led interventions.
• A health-led approach to drug use, treating addiction as a public health issue rather than a criminal justice issue.
• Expanded harm reduction services, including supervised injection facilities, drug checking services, and naloxone distribution.
• Reform of the Misuse of Drugs Act to reflect current evidence and best practice.
• Investment in evidence-based treatment and recovery services.

These recommendations were not radical. They reflected the overwhelming consensus of global evidence. They were consistent with the policies adopted by Portugal, the Czech Republic, and numerous other countries. They were delivered by ordinary Irish citizens who had spent months studying the evidence.

The Cannabis Risk Alliance and the Stacking of the Assembly

The Assembly was not without controversy. It was, in fact, compromised from the start — and the evidence points not to incompetence but to a deliberate effort to steer the outcome.

At the centre of the controversy is the Cannabis Risk Alliance (CRA), a group of approximately 20 GPs, psychiatrists, and other medical professionals who have campaigned consistently against any relaxation of Ireland's cannabis laws. The group's existence and membership were revealed by TheJournal.ie through Freedom of Information requests. Key members include:^[17]

• Dr Ray Walley — former president of the Irish Medical Organisation, moderator of the CRA
• Prof Bobby Smyth — consultant child and adolescent psychiatrist at Trinity College Dublin
• Prof Mary Cannon — Professor of Psychiatric Epidemiology and Youth Mental Health at RCSI
• Dr Matthew Sadlier and Dr Hugh Gallagher

In January 2021, five CRA members — Walley, Cannon, Sadlier, Smyth, and Gallagher — met privately with junior drugs minister Frank Feighan to discuss drug policy and a proposed RSA-style anti-cannabis advertising campaign. The CRA told the minister there should be “full transparency” around lobbyists engaging with his department — while simultaneously exploiting a loophole in Ireland's lobbying regulations that meant their own communications with government did not have to be recorded on the Lobbying Register. They demanded transparency from others while exempting themselves.

Then came the Citizens' Assembly. Prof Bobby Smyth was selected as an expert panellist to present evidence to the 99 citizens. His position on cannabis was well-known: he had presented to the Oireachtas Joint Committee on Justice as a representative of the Cannabis Risk Alliance, had published extensively against liberalisation, and was a consistent public voice against any relaxation of cannabis laws. He was framed to the Assembly as a medical expert. He was, in fact, a campaigner.

But Smyth wasn't the only CRA member with a role in the Assembly. Prof Mary Cannon — his fellow CRA member — was appointed to the Advisory Support Group, the body that designed the Assembly's work programme, selected which experts would present, and shaped the evidence the 99 citizens would hear. A member of an anti-cannabis lobbying group was given direct influence over the design of the process that was supposed to produce an impartial democratic deliberation on drug policy.

This is not how citizens' assemblies are supposed to work. The entire model depends on the Advisory Support Group being impartial, the expert selection being balanced, and the citizens receiving evidence that represents the full spectrum of informed opinion. When a lobbying group has members on the advisory panel selecting experts, and those experts include their own colleagues, the process is structurally compromised — regardless of whether the 99 citizens themselves acted in good faith (which, by all accounts, they did).

The Government's Response: Silence

The Assembly delivered its final report in 2023. The government acknowledged receipt. It expressed gratitude to the citizens for their service. It said it would “carefully consider” the recommendations.

And then it did nothing.

No legislation was introduced. No policy was changed. No timeline was published. No minister championed the recommendations. The Assembly's work — months of deliberation, evidence, and democratic engagement — was filed and forgotten.

The Democratic Damage

The failure to act on the Citizens' Assembly on Drug Use is not just a policy failure. It is a democratic failure. Citizens' assemblies derive their legitimacy from a compact: the government convenes an assembly, citizens deliberate in good faith, and the government acts on the results. When the government breaks that compact, it doesn't just ignore a set of recommendations — it undermines the legitimacy of deliberative democracy itself.

Compare the treatment of the Citizens' Assembly on Drug Use with the Citizens' Assembly on the Eighth Amendment (abortion). In that case, the Assembly's recommendations were translated into a referendum, the referendum was won, and the law was changed. The process worked. It demonstrated that Irish citizens, when given evidence and time to deliberate, could navigate complex moral and political questions with wisdom and maturity.

So what was different about drugs? The evidence was equally clear. The Assembly was equally rigorous. The recommendations were equally decisive. The only difference was political courage. The government was willing to act on abortion because public opinion had already shifted decisively. On drugs, the polling was favourable but the tabloid headlines were not. And so the government chose cowardice over democracy.

Every future Citizens' Assembly will operate under this shadow. Why would citizens invest their time and effort in deliberation if the government can simply ignore the results? The damage extends far beyond drug policy. It corrodes the very mechanism of participatory democracy that Ireland has pioneered.

05 The Global Evidence

Ireland is not operating in an evidential vacuum. Dozens of countries have reformed their cannabis and drug laws, and the data is now extensive. The results are consistent: decriminalisation and legalisation work. Prohibition does not.

Other Countries

The Netherlands has operated a “tolerance policy” (gedoogbeleid) since the 1970s, permitting the sale of small amounts of cannabis through licensed coffee shops. Cannabis use rates in the Netherlands are lower than in most European countries, including countries with stricter prohibition.^[20]

Spain permits cannabis social clubs — private, non-profit associations where members collectively cultivate and consume cannabis. There are an estimated 800+ clubs across Spain, particularly concentrated in Catalonia and the Basque Country.

Thailand legalised cannabis in 2022, becoming the first Asian country to do so. The move was partially reversed in 2024 amid concerns about unregulated commercialisation, but medical and therapeutic use remains legal. Thailand's experience demonstrates the importance of implementing a robust regulatory framework alongside legalisation.

The pattern is clear. Country after country has moved toward evidence-based drug policy. The evidence base is now so extensive that continued prohibition cannot be characterised as cautious or prudent. It is wilful ignorance.

06 The Irish Business Case

The moral and evidential case for cannabis legalisation is overwhelming. But for politicians who lack the courage to do the right thing, perhaps the economic case will suffice. Because the numbers are extraordinary.

Tax Revenue

Canada, with a population of 40 million, generates over CAD $1.5 billion annually in cannabis tax revenue. Colorado, with a population of 5.8 million (roughly equivalent to the Republic of Ireland plus Northern Ireland), has generated over $2.2 billion in cumulative tax revenue since 2014.^[21]

Applying per-capita comparisons to Ireland's population of 5.1 million and adjusting for purchasing power and consumption patterns, conservative estimates suggest Ireland could generate between €300 million and €500 million annually in cannabis tax revenue. That is revenue currently going untaxed to criminal organisations.

Job Creation

The Canadian cannabis industry employs over 150,000 people directly. Scaled to Ireland's population, this suggests 5,000 to 15,000 direct jobs in a legal Irish cannabis industry, spanning cultivation, processing, retail, quality testing, compliance, distribution, and ancillary services. Many of these jobs would be in rural areas where agricultural employment is declining.

Agricultural Opportunity

Ireland's climate is ideal for both cannabis and hemp cultivation. A legal industry would create demand for agricultural land, support farm diversification, and provide a high-value crop for Irish farmers. Cannabis cultivation could be integrated with existing agricultural infrastructure and expertise. Ireland already has world-class agricultural research institutions that could lead in cannabis agronomy.

Tourism

Cannabis tourism is a growing global sector. Amsterdam's coffee shops are a major tourism draw. Colorado's cannabis dispensaries attract visitors from across the United States. Thailand's brief experiment with cannabis tourism generated significant revenue. Ireland, with its existing tourism infrastructure and international brand, could develop a cannabis tourism offering that complements its existing strengths — particularly in the context of food tourism and wellness tourism.

Pharmaceutical Research and Manufacturing

Ireland is already one of Europe's most important pharmaceutical manufacturing hubs. Nine of the world's top ten pharmaceutical companies have operations in Ireland. Cannabis-derived pharmaceuticals — including cannabinoid-based medicines for epilepsy, chronic pain, multiple sclerosis, and anxiety — represent a rapidly growing market. A legal cannabis framework would allow Irish pharmaceutical companies to engage in cannabis research, clinical trials, and GMP manufacturing, leveraging existing infrastructure and expertise.

Criminal Market Destruction

Every euro spent in a legal, regulated cannabis market is a euro that does not go to organised crime. The Irish cannabis market is estimated at €500 million to €1 billion annually — all of it currently flowing to criminal gangs. Legalisation does not merely redirect this money to the legitimate economy through taxes and wages. It actively defunds the organisations responsible for violence, intimidation, and exploitation in Irish communities.

Criminal Justice Savings

Cannabis-related policing, prosecution, and incarceration cost the Irish state tens of millions annually. Garda time spent on cannabis possession offences — from street-level stops to court appearances to paperwork — is time not spent on serious and violent crime. Every cannabis prosecution that moves through the courts consumes judicial resources. Every sentence served consumes prison capacity. Legalisation would free all of these resources for genuine priorities.

Public Health

A regulated market means quality control. It means dosage information on packaging. It means age verification at point of sale. It means products tested for pesticides, heavy metals, mould, and synthetic adulterants. It means consumers know exactly what they are putting in their bodies.

The unregulated market offers none of this. Cannabis purchased from criminal sources may be contaminated with anything from glass particles to synthetic cannabinoids. The latter — substances like MDMB-4en-PINACA — have been linked to serious hospitalisations and deaths across Europe. Regulation doesn't just reduce harm. It prevents it.

07 The Medical Cannabis Farce

In 2019, the Irish government launched the Medical Cannabis Access Programme (MCAP) with great fanfare. It was presented as a compassionate, evidence-based initiative that would give suffering patients access to cannabis-based treatments. It was, in practice, designed to fail.

How the MCAP Was Designed to Fail

Narrow eligibility. The MCAP initially covered only three qualifying conditions: spasticity associated with multiple sclerosis, intractable nausea and vomiting associated with chemotherapy, and severe, treatment-resistant epilepsy. Chronic pain — the single most common reason for medical cannabis prescriptions worldwide — was excluded. PTSD was excluded. Anxiety was excluded. Fibromyalgia was excluded. The conditions chosen were so narrow that they excluded the vast majority of patients who could benefit from medical cannabis.^[22]

Bureaucratic burden. To prescribe under the MCAP, a consultant (not a GP — a hospital consultant) must apply to the Health Products Regulatory Authority on behalf of the patient. The application process is cumbersome. The consultant must demonstrate that all conventional treatments have been tried and failed. The consultant bears personal regulatory risk. The result is that almost no consultants are willing to prescribe. The few who do face delays measured in months.

Cost. Medical cannabis products under the MCAP are not covered by the medical card or the Drug Payment Scheme. Patients must pay out of pocket. Costs can reach €1,000 per month — a prohibitive sum for many of the people who need it most.

Hostile advisory structure. Dr Bobby Smyth — the same psychiatrist who appeared as an “expert” panellist at the Citizens' Assembly — served on advisory bodies that influenced the MCAP's design. His publicly stated opposition to cannabis access was well-documented. Placing a known opponent of medical cannabis on the advisory panel that shaped the access programme represents, at minimum, a structural conflict of interest. The MCAP was not designed by people who wanted it to succeed.

Vera Twomey and the Human Cost

The MCAP's failure has a human face. In 2016, Vera Twomey began a public campaign to access cannabis oil for her daughter Ava, who suffered from Dravet syndrome — a severe form of epilepsy. Conventional treatments had failed. Cannabis-based treatments, available in other countries, were showing dramatic results for children with the same condition. Vera could see the evidence. She could see the treatment working for other children. But in Ireland, she could not access it.^[23]

Vera Twomey walked 260 kilometres from her home in Cork to the Dáil in Dublin to demand access to medical cannabis for her daughter. She made the journey on foot. She was met with sympathy, media coverage, and ultimately — after years of campaigning — a ministerial licence that allowed Ava to access cannabis oil.

The fact that a mother had to walk across Ireland to secure legal access to a medicine available in pharmacies in most developed countries tells you everything you need to know about this country's approach to medical cannabis. It is not a policy. It is cruelty administered through bureaucracy.

08 A New Model for Criminal Justice

This investigation is not just a critique. It is a proposal. What follows is a model for drug policy and criminal justice reform that is both compassionate and uncompromising — that distinguishes clearly between substances, between users and suppliers, and between punishment and rehabilitation.

This model is not soft. It is more demanding than anything the current system asks of anyone. It requires prisoners to actively engage with their rehabilitation — to learn, to change, to demonstrate growth, to earn their freedom through achievement. It requires the state to invest in facilities, staff, and programmes that actually work. It requires politicians to explain to voters that rehabilitation is not weakness — it is the only strategy that actually reduces crime.

It is, in every measurable way, harder than sitting in a cell and waiting for the clock to run out. But it works. And anything that works is better than what we have now.

09 Who Benefits from Prohibition?

Whenever a policy persists despite overwhelming evidence against it, the question to ask is not “why does this policy exist?” but “who benefits from its continuation?”

Criminal Organisations

The primary beneficiaries of cannabis prohibition are criminal gangs. In a prohibited market, criminals are the only suppliers. They set the price, the quality, the terms. They face no competition from legal businesses, no regulatory oversight, no quality standards. Prohibition is not a barrier to the cannabis trade. It is a business model — and it belongs to organised crime. Every day that cannabis remains illegal in Ireland is another day that criminal gangs have a monopoly on a product that millions of people want to buy.

The Alcohol Industry

The alcohol industry has a documented history of lobbying against cannabis legalisation. In the United States, beer, wine, and spirits companies have donated to anti-legalisation campaigns. The logic is straightforward: cannabis is a substitute for alcohol, and a legal cannabis market would reduce alcohol consumption. Research from legal US states confirms this — alcohol sales have declined in states that have legalised cannabis.^[26] In Ireland, where the drinks industry wields significant political influence, this economic self-interest aligns with the status quo.

The Pharmaceutical Industry

Cannabis is a potential competitor to a range of pharmaceutical products: painkillers, anti-anxiety medications, sleep aids, anti-nausea drugs, and certain epilepsy treatments. While some pharmaceutical companies have invested in cannabinoid research, the industry as a whole has an incentive to maintain the regulatory barriers that prevent cannabis from competing with patented products. A plant that patients can grow in their garden is not a business model that pharmaceutical shareholders welcome.

Politicians

“Tough on drugs” is a positioning tool. It signals authority, moral seriousness, and concern for public safety — regardless of whether the policies it describes actually work. For politicians who lack the courage or the inclination to engage with evidence, prohibition is a comfortable default. It requires no new legislation, no regulatory design, no public education, no political risk. The status quo is always the safest position for a coward.

Who Does NOT Benefit

• Cannabis users: criminalised, stigmatised, pushed toward unregulated products of unknown quality and safety.
• Families: dealing with the consequences of criminal records, incarceration, and the social stigma attached to drug convictions.
• Communities: subjected to the violence, intimidation, and antisocial behaviour associated with criminal drug markets.
• Taxpayers: funding the policing, prosecution, and incarceration of cannabis offences instead of receiving tax revenue from a regulated market.
• Public health: denied the benefits of regulation, quality control, and evidence-based harm reduction.
• The economy: missing out on hundreds of millions in tax revenue, thousands of jobs, and agricultural and pharmaceutical opportunities.
• Democracy: undermined by a government that convenes citizens' assemblies and then ignores their recommendations.

10 Conclusion: The Cost of Cowardice

The case for cannabis legalisation in Ireland is not marginal. It is not balanced on a knife-edge of contested evidence. It is overwhelming. It is supported by the country's own Citizens' Assembly. It is supported by 25 years of Portuguese data, eight years of Canadian data, 14 years of Coloradan data. It is supported by the World Health Organisation, the Global Commission on Drug Policy, the British Medical Journal, The Lancet, and the vast majority of addiction specialists and public health researchers worldwide.

Ireland has the evidence. It has the democratic mandate. It has the economic incentive. It has the agricultural conditions. It has the pharmaceutical infrastructure. It has the progressive social track record.

What it lacks is political courage.

Every year that Ireland maintains cannabis prohibition:

• €500 million to €1 billion flows to criminal organisations instead of the exchequer
• Thousands of people receive criminal records for possessing a substance less harmful than alcohol
• Patients who could benefit from medical cannabis are denied access or forced to travel abroad
• Farmers are denied the opportunity to grow one of the most versatile and profitable crops suited to Irish conditions
• Communities remain subject to the violence and exploitation of criminal drug markets
• Democracy is diminished by a government that treats citizens' assemblies as consultative exercises rather than democratic mandates

The question is not whether Ireland will legalise cannabis. The global trajectory is clear. The question is how many more lives will be damaged, how much more revenue will be lost, and how much more democratic credibility will be squandered before Irish politicians find the spine to act on evidence they already have.

Cannabis prohibition was designed by racists, enforced by cowards, and maintained by inertia. Ireland deserves better. Its citizens have already said so. It is past time their government listened.